The present invention relates to the prediction of antipsychotic treatment efficacy based on a patient's genotype at one or more single nucleotide polymorphism (SNP) loci associated with iloperidone efficacy and to the treatment of a patient based on such prediction.
申请公布号
CA2699786(A1)
申请公布日期
2009.03.19
申请号
CA20082699786
申请日期
2008.09.10
申请人
VANDA PHARMACEUTICALS, INC.
发明人
LAVEDAN, CHRISTIAN;VOLPI, SIMONA;LICAMELE, LOUIS;POLYMEROPOULOS, MIHAEL H.
